Finding Calm Instead of Forcing Chaos
Your cardiologist threads a pressure wire through the blockage, then injects adenosine. Chest tightness. Breathlessness. Flushing. Seventy-eight percent of patients feel this during fractional flow reserve measurement—the accepted cost of knowing whether that narrowing actually restricts blood flow enough to warrant a stent.
FFR has twenty years of evidence showing it guides smarter treatment decisions than visual assessment alone. The drug-induced stress it requires has kept adoption below 10% worldwide despite that track record. But the ideal conditions FFR creates through pharmaceutical force already occur naturally during a specific window of each heartbeat.
Finding Calm Instead of Forcing Chaos
Your cardiologist threads a pressure wire through the blockage, then injects adenosine. Chest tightness. Breathlessness. Flushing. Seventy-eight percent of patients feel this during fractional flow reserve measurement—the accepted cost of knowing whether that narrowing actually restricts blood flow enough to warrant a stent.
FFR has twenty years of evidence showing it guides smarter treatment decisions than visual assessment alone. The drug-induced stress it requires has kept adoption below 10% worldwide despite that track record. But the ideal conditions FFR creates through pharmaceutical force already occur naturally during a specific window of each heartbeat.
Research Fuels Patient Advocacy
When Women Bleed After Stenting, They Die More Often—And the Reason Matters
Women who bleed after coronary stenting face 28% higher mortality than men who bleed. The antiplatelet protocols your cardiologist follows were tested in trials where 75% of participants were male. Standard dosing, monitoring, follow-up schedules—all validated predominantly in male physiology. When bleeding occurs in women, the response protocols may not account for sex-specific differences. Your cardiologist will likely not mention these statistics unless you ask.
Three Critical Moments in Your Stenting Discussion
Your cardiologist recommends standard dual antiplatelet therapy after stenting. You understand the evidence: double the bleeding risk, 28% higher mortality when complications occur, protocols validated in trials where most participants were men. Three moments in this conversation will determine whether your care accounts for sex-specific risks. The first happens when your doctor says "This is our standard protocol." What you say next matters.
Evidence in Your Pocket
Swedish Study: Bioadaptors Cut Heart Problems in Half
A Swedish study of 2,400 patients showed bioadaptors nearly halved the need for repeat procedures after six months.
Heart attack patients saw the strongest protection, exactly the group that needs the most reliable long-term results.
Evidence in Your Pocket
Three Years Later, Bioadaptors Still Outperform Standard Stents
This is the first proof that bioadaptors maintain their advantage for three full years, not just months.
EuroPCR 2025 data showed bioadaptors reduced cardiovascular death rates from 3.2% to 0.5% over three years.
Evidence in Your Pocket
Drug Balloon Treats Repeat Blockages Without Adding Metal
Here's the advantage: If you've already got stents and develop new blockages, this balloon avoids adding more metal layers.
"The SELUTION4ISR trial showed drug balloons work as well as repeat stenting for my situation, right?"
Evidence in Your Pocket
Half of Stents Aren't Placed Optimally, Study Finds
Simply having imaging technology doesn't guarantee proper technique, and there's substantial room for improvement in actual placement.
"Will you use imaging during my procedure, and which specific criteria will you check for optimal placement?"